Menu
Search
|

Menu

Close
X

Bayer AG BAYGN.DE (Xetra)

92.05 EUR
-0.30 (-0.32%)
As of Jul 19
chart
Previous Close 92.35
Open 92.10
Volume 4,626,312
3m Avg Volume 3,242,010
Today’s High 93.35
Today’s Low 91.48
52 Week High 118.04
52 Week Low 87.40
Shares Outstanding (mil) 932.55
Market Capitalization (mil) 86,690.03
Forward P/E 22.28
Dividend (Yield %) 2.76 ( 2.98 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 25 analysts

KEY STATS

Revenue (mm, EUR)
FY18
9,138
FY17
38,494
FY16
40,768
FY15
46,085
EPS (EUR)
FY18
2.195
FY17
3.726
FY16
4.791
FY15
4.790
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.28
33.05
Price to Sales (TTM)
vs sector
2.51
8.10
Price to Book (MRQ)
vs sector
2.02
4.20
Price to Cash Flow (TTM)
vs sector
13.96
22.23
Total Debt to Equity (MRQ)
vs sector
36.62
17.32
LT Debt to Equity (MRQ)
vs sector
32.02
13.18
Return on Investment (TTM)
vs sector
5.56
13.17
Return on Equity (TTM)
vs sector
10.22
15.10

EXECUTIVE LEADERSHIP

Werner Wenning
Chairman of the Supervisory Board, Since 2012
Salary: €360,000.00
Bonus: --
Werner Baumann
Chairman of the Management Board, Chief Executive Officer, Since 2016
Salary: €1,487,000.00
Bonus: €49,000.00
Oliver Zuehlke
Vice Chairman of the Supervisory Board, Employee Representative, Since 2015
Salary: €240,000.00
Bonus: --
Hartmut Klusik
Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director, Since 2016
Salary: €756,000.00
Bonus: €40,000.00
Jennifer Brendelto
Vice President - Communications of the Consumer Health Division, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Kaiser-Wilhelm-Allee 1
LEVERKUSEN     51373

Phone: +49214.301

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

SPONSORED STORIES